Loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool?

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 263-268

  Rodríguez, María J ^a   Acha, Amelia ^a   Ruesga, María T ^a   Rodríguez, Carlos ^a   Rivera, José M ^a   Aguirre, José M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Immunohistochemistry; Leukoplakia; MGMT; Oral squamous cell carcinoma; Tobacco

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ADULT; ALKYLATION; ARTICLE; CANCER RISK; CARCINOGENICITY; CLINICAL FEATURE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

ADULT; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROGNOSIS; SMOKING; TIME FACTORS;

NICOTIANA TABACUM;

EID: 33845607550     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.01.015     Document Type: Article

References (30)

1. Izarzugaza M.I., Esparza H., and Aguirre J.M. Epidemiological aspects of oral and pharyngeal cancers in the Basque Country. J. Oral. Pathol. Med. 30 (2001) 521-526
2. Patel V., Leethanakul C., and Gutkind J.S. New approaches to the understanding of the molecular basis of oral cancer. Crit. Rev. Oral. Biol. Med. 12 (2001) 55-63
3. Gerson S.L. MGMT: its role in cancer aetiology and cancer therapeutics. Nat. Rev. Cancer. 4 (2004) 296-307
4. Singer B. Alkylating of the O6 of guanine is only one of many chemical events that may initiate carcinogenesis. Cancer Invest. 2 (1984) 233-238
5. Shields P.G. Epidemiology of tobacco carcinogenesis. Curr. Oncol. Rep. 2 (2000) 257-262
6. Safhill R., Margison G.P., and O'Connor P.J. Mechanisms of carcinogenesis induced by alkylating agents. Biochim. Biophys. Acta 823 (1985) 111-145
7. Ishibashi T., Nakabeppu Y., and Sekiguchi M. Artificial control of nuclear translocation of DNA repairs methyltransferase. J. Biol. Chem. 269 (1994) 7645-7650
8. Esteller M., Toyota M., Sánchez C.M., Capella G., Peinado M.A., Watkins D.N., et al. Inactivation of the DNA repair gene O (6)-methylguanine-DNA methyltransferase gene is associated with G to A mutations in K- ras in colorectal tumorogenesis. Cancer Res. 60 (2000) 2368-2371
9. Esteller M., Risques R.A., Toyota M., Capella G., Moreno V., Peinado M.A., et al. Promoter hypermethylation of the DNA repair gene O (6)-methylguanine-DNA-methyltransferase by promoter hypermethylation is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorogenesis. Cancer Res. 61 (2001) 4689-4692
10. Egyhazi S., Ma S., Smoczynski K., Hansson J., Platz A., and Ringborg U. Novel O (6)-methylguanine-DNA methylguanine-DNA methyltransferase SNPs: a frequency comparison of patients with familiar melanoma and healthy individuals in sweden. Hum. Mutat. 20 (2002) 408-409
11. Sepehr A., Kamangar F., Abnet C.C., Fahimi S., Pourshams A., Poustchi H., et al. Genetic polymorphism in three Iranian populations with different risks on esophageal cancer, an ecologic comparison. Cancer Lett. 213 (2004) 195-202
12. Cohet C., Borel S., Nyberg F., Mukeria A., Brüske-Hohlfeld I., Constantinescu V., et al. Exon 5 polymorphism in the O(6)- alkyltransferase gene and lung cancer risk in non-smokers exposed to second-hand smoke. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 320-323
13. Matsukura S., Miyazaki K., Yakushiji H., Ogawa A., Harimaya K., Nakabeppu Y., and Sekiguchi M. Expression and prognostic significance of O (6)-methylguanine-DNA- methyltransferase in hepatocellular, gastric and breast cancer. Ann. Surg. Oncol. 8 (2001) 807-816
14. Nozoe T., Korenaga D., Kabashima A., and Sugimachi K. Smoking-related increase of O (6)-methylguanine-DNA methyltransferase expression in squamous cell carcinoma of the esophagus. Cancer Lett. 184 (2002) 49-55
15. Kitajima Y., Miyazaki K., Matsukura S., Tanaka M., and Sekiguchi M. Loss of expression of DNA repair enzymes MGMT, h MLH1 and h MSH2 during tumor progression in gastric cancer. Gastric Cancer 6 (2003) 86-95
16. Zuo C., Ai L., Ratliff P., Suen J.Y., Hanna E., Brent T.P., and Fan C.Y. O (6)-methylguanine-DNA-methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 967-975
17. Martínez-Conde R., Aguirre J.M., Burgos J.J., and Rivera J.M. Clinicopathological factors in early squamous cell carcinoma of the tongue and floor of the mouth, in Biscay (The Basque Country, Spain). Med. Oral. 6 (2001) 87-94
18. Zaidi N.H., Liu L., and Gerson S.L. Quantitative immunohistochemical estimates of O6 alkylguanine-DNA alkytransferase expression in normal and malignant human colon. Clin. Cancer Res. 3 (1996) 577-584
19. Sánchez-Cespedes M., Esteller M., Wu L., Nawroz-Danish H., Yoo G.H., Koch W.M., et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 60 (2000) 892-895
20. Rosas S.L.P., Koch W., Carvalho M.G.C., Wu L., Califano J., Westra W., et al. Promoter hypermethylation patterns of p16, O (6)-methylguanine-DNA-methyltransferase, and death-asociated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61 (2001) 939-942
21. López M., Aguirre J.M., Cuevas N., Anzola M., Videgain J., Aguirregaviria J., and Martinez de Pancorbo M. Gene promoter hypermethylation in oral rinses of leukoplakia patients-a diagnostic and/or prognostic tool. Eur. J. Cancer. 39 (2003) 2306-2309
22. Viswanathan M., Tsuchida N., and Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int. J. Cancer 105 (2003) 41-46
23. Kulkarni V., and Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinoma and adjacent normal tissues. Oral. Oncol. 40 (2004) 145-153
24. Esteller M., Hamilton S., Burger P., Baylin S., and Herman J. Inactivation of the DNA repair gene O (6)-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 15 (1999) 793-797
25. Esteller M., and Herman J.G. Generating mutations but providing chemosensitivity: the role of O (6)-methylguanine DNA methyltransferase in human cancer. Oncogene 23 (2004) 1-8
26. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 629-656
27. Maki Y., Murakami J., Asaumi J., Tsujigiwa H., Nagatsuka H., Kokeguchi S., et al. Role of O (6)-methylguanine-DNA methyltranferase and effect of O (6)-benzylguanine on the anti-tumor activity of cis- diaminedichloroplatinium (II) in oral cell lines. Oral. Oncol. 41 (2005) 984-993
28. Digel W., and Lübbert M. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results. Crit. Rev. Oncol. Hematol. 55 (2005) 1-11
29. Peterson L.A., Thomson N.M., Crankshaw D.L., Donaldson E.E., and Kenney P.J. Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorogenesis. Cancer Res. 61 (2001) 5757-5763
30. Rohatgi N., Kaur J., Srivastava A., and Ralhan R. Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from oral hyperplasia. Oral. Oncol. 41 (2005) 806-820